Antipsychotic drug effects on glutamatergic activity

Brain Research

Volumn 764, Issue 1-2, 1997, Pages 46-52

  Lidsky, T I ^a   Yablonsky Alter, E ^b   Zuck, L G ^a   Banerjee, S P ^b  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

Antipsychotic; Glutamate; N Methyl D aspartate; Neuroleptic; Partial agonist; Schizophrenia; Tardive dyskinesia

Indexed keywords

CHLORPROMAZINE; METOCLOPRAMIDE; PROMAZINE; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE DEPOLARIZATION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ELECTROPHYSIOLOGY; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; RETINA GANGLION CELL; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; BRAIN CHEMISTRY; DOPAMINE ANTAGONISTS; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMATES; MALE; METOCLOPRAMIDE; PHENOTHIAZINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

EID: 0030954746     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00423-X     Document Type: Article

References (41)

1. R.J. Baldessarini, Drugs and the treatment of psychiatric disorders. In A. Goodman-Gilman, T.W. Rall, A.S. Nies, P. Taylor (Eds.) Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th edn., Pergamon Press, New York (1990) pp. 383-435.
2. S.P. Banerjee, L.G. Zuck, E. Yablonsky-Alter, T.I. Lidsky, Glutamate agonist activity: implications for antipsychotic drug action and schizophrenia, NeuroReport 6 (1995) 2500-2504.
3. S.P. Banerjee, S.H. Snyder, P. Cuatrecasas, L.A. Greene, Binding of nerve growth factor in sympathetic ganglia, Proc. Natl. Acad. Sci. USA 70 (1973) 2519-2522.
4. L.L. Brunton, Agents affecting gastrointestinal water flux and motility, digestants, and bile acids. In A. Goodman-Gilman, T.W. Rall, A.S. Nies, P. Taylor (Eds.) Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th edn., Pergamon Press, New York (1990) pp. 914-932.
5. M. Carlsson, A. Carlsson, Interactions between glutamatergic and monoaminergic systems within the basal ganglia: implications for schizophrenia and Parkinson's disease, Trends Neurosci. 13 (1990) 272-276.
6. C. Cepeda, Z. Radisavljevic, W. Peacock, M.S. Levine, N.A. Buchwald, Differential modulation by dopamine of responses evoked by excitatory amino acids in human cortex, Synapse 11 (1992) 330-341.
7. E. Cherubini, P.L. Herrling, L. Lanfumey, P. Stanzione, Excitatory amino acids in synaptic excitation of rat striatal neurones in vitro, J. Physiol. 400 (1988) 67-69.
8. C.S. Colwell, M.S. Levine, Excitatory synaptic transmission in neostriatal neurons: regulation by cyclic AMP-dependent mechanisms, J. Neurosci. 15 (1995) 1704-1713.
9. L.W. Fitzgerald, A.Y. Deutch, G. Gasic, S.F. Heinemann, E.J. Nestler, Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs, J. Neurosci. 15 (1995) 2453-2461.
10. E.J. Fletcher, J.F. MacDonald, Haloperidol interacts with the strychnine-insensitive glycine site at the NMDA receptor in cultured mouse hippocampal neurones, Eur. J. Pharmacol. 235 (1993) 291-295.
11. A.A. Grace, B.S. Bunney, H. Moore, C.L. Todd, Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs, Trends Neurosci. 20 (1996) 31-37.
12. D.C. Javitt, S.R. Zukin, Recent advances in the phencyclidine model of schizophrenia, Am. J. Psychiat. 148 (1991) 1301-1308.
13. L. Kerkerian, N. Dusticier, A. Nieoullon, Modulatory effect of dopamine on high-affinity glutamate uptake in the rat striatum, J. Neurochem. 48 (1987) 1301-1306.
14. J.S. Kim, H.H. Kornhuber, W. Schnid-Burgk, B. Holzmuller, Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia, Neurosci. Lett. 20 (1980) 379-382.
15. S.T. Kitai, H. Kita, Electrophysiological study of the neostriatum in brain slice preparation. In R. Dingledine (Ed.) Brain Slices. Plenum Press, New York (1984) pp. 285-296.
16. A.G. Knapp, J.E. Dowling, Dopamine enhances excitatory amino acid-gated conductances in cultured retinal horizontal cells, Nature 325 (1987) 437-439.
17. T.I. Lidsky, S.P. Banerjee, Contribution of glutamatergic dysfunction to schizophrenia, Drug News Perspectives 9 (1996) 453-459.
18. T.I. Lidsky, J.S. Schneider, L.G. Zuck, E. Yablonsky-Alter, S.P. Banerjee, GM1 ganglioside attenuates changes in neurochemistry and behaviour caused by repeated haloperidol administration, Neurodegeneration 3 (1994) 135-140.
19. D.M. Lovinger, B.A. McCool, Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGluR2 or 3, J. Neurophysiol. 73 (1995) 1076-1083.
20. D.M. Lovinger, E.C. Tyler, A. Merritt, Short- and long-term synaptic depression in rat neostriatum, J. Neurophysiol. 70 (1993) 1937-1949.
21. G. Maguire, F. Werblin, Dopamine enhances a glutamate-gated ionic current in OFF bipolar cells of the tiger salamander retina, J. Neurosci. 14 (1994) 6094-6101.
22. L. McCoy, E.K. Richfield, Chronic antipsychotic treatment alters glycine-stimulated NMDA receptor binding in rat brain, Neurosci. Lett. 213 (1996) 137-141.
23. J.H. Meador-Woodruff, R.E. King, S.P. Damask, K.A. Bovenkerk, Differential regulation of hippocampal AMPA and kainate receptor subunit expression by haloperidol and clozapine, Mol. Psychiat. 1 (1996) 41-53.
24. H.Y. Meltzer, The mechanism of action of novel antipsychotic drugs, Schiz. Bull. 17 (1991) 263-287.
25. i values, J. Pharmacol. Exptl. Therapeut. 251 (1989) 238-246.
26. C.K. Meshul, S.-E. Tan, Haloperidol-induced morphological alterations are associated with changes in calcium/calmodulin kinase II activity and glutamate immunoreactivity, Synapse 18 (1994) 205-217.
27. C.K. Meshul, G.L. Bunker, J.N. Mason, C. Allen, A. Janowsky, Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses, J. Neurochem. 67 (1996) 1965-1973.
28. M.E. Pucak, A.A. Grace, Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors, J. Pharm. Exptl. Therapeut. 271 (1994) 1181-1192.
29. 3H-Labeled MK-801 binding to the excitatory amino acid complex from rat brain is enhanced by glycine, Proc. Natl. Acad. Sci. USA 84 (1987) 7744-7748.
30. 3H]MK801 binding to the N-methyl-D-aspartate receptor reveals drug interactions with the zinc and magnesium binding sites, J. Pharmacol. Exptl. Therapeut. 247 (1988) 1025-1031.
31. G.E. Rovati, S. Nicosia, Lower efficacy: interaction with an inhibitory receptor or partial agonism?, Trends Pharmacol. Sci. 15 (1994) 140-144.
32. R.E. See, A.M. Lynch, Chronic haloperidol potentiates stimulated glutamate release in caudate putamen, but not prefrontal cortex, Neuropharmacol. Neurotoxicol. 6 (1995) 1795-1798.
33. 4, Neuropsychopharmacology 7 (1992) 261-284.
34. A.D. Sherman, A.T. Davidson, S. Baruah, T.S. Hegwood, R. Waziri, Evidence of glutamatergic deficiency in schizophrenia, Neurosci. Lett. 121 (1991) 77-80.
35. S.M. Siviy, N.A. Buchwald, M.S. Levine, Enhanced responses to NMDA receptor activiation in the developing cat caudate nucleus, Neurosci. Lett. 132 (1991) 77-81.
36. I.D. Smith, A.A. Grace, Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity, Synapse 12 (1992) 287-303.
37. H.L. Sudan, K.S.J. Thompson, I. Phillips, P.L. Needham, K.F. Martin, D.J. Heal, Effects of haloperidol on rat excitatory amino acid receptors: comparing the Xenopus oocyte expression system with the cortical wedge preparation, Neurosci. Soc. Abstr. 22 (1996) 1543.
38. 1-dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons, Neuron 14 (1995) 385-397.
39. J.P. Walsh, Depression of excitatory synaptic input in rat striatal neurons, Brain Res. 608 (1993) 123-128.
40. J.P. Walsh, R. Dunia, Synaptic activation of N-methyl-D-aspartate receptors induces short-term potentiation at excitatory synapses in the striatum of the rat, Neuroscience 57 (1993) 241-248.
41. L. Wilkinson, SYSTAT: The System for Statistics. SYSTAT, Stasoft, Tulsa, OK, 1990.